Molecule Information
General Information of the Molecule (ID: Mol00999)
Name |
MATE family efflux transporter (ABEM)
,Acinetobacter baumannii
|
||||
---|---|---|---|---|---|
Synonyms |
abeM; norM_1; norM_2; A7M90_01030; ABCAM1_0400; ABR2091_0395; APD31_09880; AUO97_09395; AYR68_01385; B7L45_17470; B9X95_14630; BS065_17005; CBE85_05175; CBL15_16565; H0529_14335; IMO23_01850; NCTC13305_02036; SAMEA104305281_01114; SAMEA104305385_01096; Multidrug ABC transporter; Multidrug efflux MATE transporter AbeM; Multidrug resistance protein norM
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
abeM
|
||||
Gene ID | |||||
Sequence |
MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPV
MLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFG VPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIF MYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKINLTWVKRI LQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIR VGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLL WFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVW LGLIIGLSIACVLLLSRLYLNTKRLSQT Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
12 drug(s) in total
Acriflavine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Acriflavine | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Chloramphenicol
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Chloramphenicol | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Ciprofloxacin XR
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Ciprofloxacin XR | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Daunorubicin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Daunorubicin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Doxorubicin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Doxorubicin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Erythromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Erythromycin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Gentamicin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Gentamicin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Kanamycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Kanamycin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Norfloxacin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Norfloxacin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Ofloxacin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Ofloxacin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Triclosan
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Triclosan | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Trimethoprim
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Trimethoprim | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Clinical Trial Drug(s)
1 drug(s) in total
Rhodamine 6G
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Rhodamine 6G | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Discontinued Drug(s)
1 drug(s) in total
Bisbenzimide (Hoechst 33258)
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Bisbenzimide (Hoechst 33258) | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Investigative Drug(s)
3 drug(s) in total
4',6-Diamidino-2-phenylindole
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | 4',6-Diamidino-2-phenylindole | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Homidium bromide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Homidium bromide | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
Tetraphenylphosphonium chloride
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Acinetobacter baumannii infection | [1] | |||
Resistant Disease | Acinetobacter baumannii infection [ICD-11: CA40.4] | |||
Resistant Drug | Tetraphenylphosphonium chloride | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | AbeM was found to be an H+-coupled multidrug efflux pump and a unique member of the MATE family which lead to drug resistance. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.